Concepedia

Christopher Roy

CR

9

Publications

887

Citations

9

H-Index

1999

Active since

Affiliations

Selecta Biosciences (United States)(Current)

Harvard University

Christopher Roy is an author at Selecta Biosciences (United States) specializing in medicine, immunology, and cell biology.

ORCID

Top concepts

Publications per year

1999–2023

9

Publications

9

Murine CD1d-Restricted T Cell Recognition of Cellular Lipids

Jenny E. Gumperz, Christopher Roy, Anna Makowska et al. · Immunity · 2000 · 469 citations · Full text

, , +4

Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration

Amine Meliani, Florence Boisgérault, Romain Hardet et al. · Nature Communications · 2018 · 241 citations · Full text

Enhancement of liver-directed transgene expression at initial and repeat doses of AAV vectors admixed with ImmTOR nanoparticles

Petr O. Ilyinskii, Alicia Michaud, Christopher Roy et al. · Science Advances · 2021 · 48 citations · Full text

ImmTOR nanoparticles enhance AAV transgene expression after initial and repeat dosing in a mouse model of methylmalonic acidemia

Petr O. Ilyinskii, Alicia Michaud, Gina L. Rizzo et al. · Molecular Therapy — Methods & Clinical Development · 2021 · 34 citations · Full text

Enhancement of the Tolerogenic Phenotype in the Liver by ImmTOR Nanoparticles

Petr O. Ilyinskii, Christopher Roy, Julie LePrevost et al. · Frontiers in Immunology · 2021 · 25 citations · Full text

Rows per page

1–5 of 9